These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 9732918

  • 1. Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study.
    Pazzi P, Scagliarini R, Sighinolfi D, Govoni M, La Corte R, Gullini S.
    Am J Gastroenterol; 1998 Sep; 93(9):1420-4. PubMed ID: 9732918
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study.
    Acalovschi M, Blendea D, Feier C, Letia AI, Ratiu N, Dumitrascu DL, Veres A.
    Am J Gastroenterol; 2003 Aug; 98(8):1856-60. PubMed ID: 12907344
    [Abstract] [Full Text] [Related]

  • 3. The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease.
    Lapidus A, Bångstad M, Aström M, Muhrbeck O.
    Am J Gastroenterol; 1999 May; 94(5):1261-6. PubMed ID: 10235204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Wolfe F, Zhao S, Pettitt D.
    J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
    [Abstract] [Full Text] [Related]

  • 7. Gallstone disease and related risk factors in a large cohort of diabetic patients.
    Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigolon A, Peracchi M, Conte D.
    Dig Liver Dis; 2004 Feb; 36(2):130-4. PubMed ID: 15002821
    [Abstract] [Full Text] [Related]

  • 8. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S.
    Arthritis Res Ther; 2005 Feb; 7(2):R333-42. PubMed ID: 15743481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence of gallstone disease in patients with diabetes mellitus. A case-control study.
    Persson GE, Thulin AJ.
    Eur J Surg; 1991 Oct; 157(10):579-82. PubMed ID: 1687247
    [Abstract] [Full Text] [Related]

  • 14. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
    Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, Rudilosso A, D'Amico R, Bertolotti M, Carulli N.
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.
    Mosis G, Stijnen T, Castellsague J, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC.
    Arthritis Rheum; 2006 Aug 15; 55(4):537-42. PubMed ID: 16874797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
    Altiparmak MR, Pamuk ON, Pamuk GE, Celik AF, Apaydin S, Cebi D, Mihmanli I, Erek E.
    Am J Gastroenterol; 2003 Apr 15; 98(4):813-20. PubMed ID: 12738461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.